Vor Biopharma Inc Financial Flexibility Index

Latest as of June 2026: -0.04x

Vor Biopharma Inc financial flexibility index. Vor Biopharma Inc (VOR) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-25.55 Million (operating CF $-25.67 Million minus capex $120.00K) represents 0% of total liabilities ($681.25 Million).

Financial Flexibility Index

-0.04x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-25.55 Million
Operating CF − Capex

Total Liabilities

$681.25 Million
USD

Capital Expenditures

$120.00K
USD

Financial Flexibility Index of Vor Biopharma Inc (2018–2025)

Financial flexibility index of Vor Biopharma Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Vor Biopharma Inc across 8 annual periods. Check Vor Biopharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Vor Biopharma Inc Financial Flexibility Index by Year (2018–2025)

Vor Biopharma Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Vor Biopharma Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Vor Biopharma Inc.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.23x $-141.77 Million $-142.71 Million $628.44 Million ▲ +89.5%
2024 -2.15x $-99.43 Million $-99.66 Million $46.23 Million ▼ -28.1%
2023 -1.68x $-99.22 Million $-100.29 Million $59.10 Million ▼ -6.7%
2022 -1.57x $-76.68 Million $-85.14 Million $48.76 Million ▲ +36.5%
2021 -2.48x $-65.25 Million $-69.14 Million $26.33 Million ▼ -113.2%
2020 -1.16x $-32.13 Million $-36.29 Million $27.64 Million ▲ +72.1%
2019 -4.17x $-9.11 Million $-9.86 Million $2.19 Million ▼ -1593.0%
2018 -0.25x $-1.91 Million $-2.66 Million $7.77 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities